These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12144572)

  • 1. Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial.
    Musch E; Andus T; Malek M
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1233-9. PubMed ID: 12144572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
    Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
    Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study.
    Nikolaus S; Rutgeerts P; Fedorak R; Steinhart AH; Wild GE; Theuer D; Möhrle J; Schreiber S
    Gut; 2003 Sep; 52(9):1286-90. PubMed ID: 12912859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial.
    Musch E; Andus T; Kruis W; Raedler A; Spehlmann M; Schreiber S; Krakamp B; Malek M; Malchow H; Zavada F; Engelberg Feurle G
    Clin Gastroenterol Hepatol; 2005 Jun; 3(6):581-6. PubMed ID: 15952100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.
    Pena Rossi C; Hanauer SB; Tomasevic R; Hunter JO; Shafran I; Graffner H
    BMC Gastroenterol; 2009 Mar; 9():22. PubMed ID: 19302707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferons for induction of remission in ulcerative colitis.
    Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis.
    Sümer N; Palabiyikoğlu M
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):597-602. PubMed ID: 8590152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study.
    Andus T; Klebl F; Rogler G; Bregenzer N; Schölmerich J; Straub RH
    Aliment Pharmacol Ther; 2003 Feb; 17(3):409-14. PubMed ID: 12562454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitis.
    Pena-Rossi C; Schreiber S; Golubovic G; Mertz-Nielsen A; Panes J; Rachmilewitz D; Shieh MJ; Simanenkov VI; Stanton D; Graffner H
    Aliment Pharmacol Ther; 2008 Sep; 28(6):758-67. PubMed ID: 19145731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.
    Schott E; Paul F; Wuerfel JT; Zipp F; Rudolph B; Wiedenmann B; Baumgart DC
    World J Gastroenterol; 2007 Jul; 13(26):3638-40. PubMed ID: 17659718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
    Fiorino G; Gilardi D; Naccarato P; Sociale OR; Danese S
    Dig Liver Dis; 2014 Apr; 46(4):330-4. PubMed ID: 24462118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
    Lazzerini M; Martelossi S; Magazzù G; Pellegrino S; Lucanto MC; Barabino A; Calvi A; Arrigo S; Lionetti P; Lorusso M; Mangiantini F; Fontana M; Zuin G; Palla G; Maggiore G; Bramuzzo M; Pellegrin MC; Maschio M; Villanacci V; Manenti S; Decorti G; De Iudicibus S; Paparazzo R; Montico M; Ventura A
    Inflamm Bowel Dis; 2015 Aug; 21(8):1739-49. PubMed ID: 26185909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
    Stallmach A; Langbein C; Atreya R; Bruns T; Dignass A; Ende K; Hampe J; Hartmann F; Neurath MF; Maul J; Preiss JC; Schmelz R; Siegmund B; Schulze H; Teich N; von Arnim U; Baumgart DC; Schmidt C
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1199-1212. PubMed ID: 27714831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production.
    Mannon PJ; Hornung RL; Yang Z; Yi C; Groden C; Friend J; Yao M; Strober W; Fuss IJ
    Gut; 2011 Apr; 60(4):449-55. PubMed ID: 20971977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
    Creed TJ; Norman MR; Probert CS; Harvey RF; Shaw IS; Smithson J; Anderson J; Moorghen M; Gupta J; Shepherd NA; Dayan CM; Hearing SD
    Aliment Pharmacol Ther; 2003 Jul; 18(1):65-75. PubMed ID: 12848627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.
    Kato K; Ohkusa T; Terao S; Chiba T; Murakami K; Yanaka A; Uehara T; Ishii Y; Soma M; Tajiri H
    Aliment Pharmacol Ther; 2014 May; 39(9):949-56. PubMed ID: 24628398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.